Data / Form D filings / Kane Biotech Inc.
Kane Biotech Inc.: Form D filing
Kane Biotech Inc., a biotechnology company in Winnipeg, filed a Form D with the SEC in 2009. The latest, on May 18, 2009, reports $42,467 sold of a $87,968 offering to 2 investors.
Find out what Kane Biotech Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1250 WAVERLY STREET, SUITE 5, Winnipeg, R3T 6
- Phone
- (204) 453-1301
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- A2
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1464368
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 18, 2009 | New notice | $87,968 | $42,467 | $45,501 | 2 | May 3, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Marcus Enns | Executive Officer | |
| Geoffrey Grant | Director | |
| Peter De Visser | Director | |
| Albert D. Friesen | Director | |
| Eric Johnstone | Executive Officer | |
| Gord Froehlich | Executive Officer | |
| George Zhanel | Director | |
| Sri Madhyastha | Executive Officer |
Every Form D from the week of May 18, 2009 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Kane Biotech Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.